共 10 条
- [1] BNP: soon to become a routine measuring in the care of patients with heart failure. Cowie MW. Heart . 2000
- [2] B-type natriuretic peptide predicats future cardiac events in patients presenting to the emergency department with dyspnea. Harrison A,Morrison LK,Krishnaswamy P,et al. Annals of Emergency Medicine . 2002
- [3] Cardiac natriuretic peptide for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation. Selvais PL. European Journal of Clinical Investigation . 1998
- [4] Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congetive heart failure. Tsutamoto T,Wada A,Madea K,et al. Journal of the American College of Cardiology . 2001
- [5] Plasma BNP level as a bilchemical marker of morbidity in patients with asympotomatic or minimally sympotomatic. Tsutamoto T. European Heart Journal . 1999
- [6] Brain natriuretic peptid as bridge to therapy for hearrt failure. Dries DL,Stevenscen LW. The Lancet . 2000
- [7] B-type natriurwtic peptide levels: a potential novel white count for congetive heart failure. Maisel A. Journal of Cardiac Failure . 2001
- [8] Biochemical detection of left-ventricular systolicdysfunction. McDonagh TA,Robb SD,Murdoch DR,et al. The Lancet . 1998
- [9] Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. Maisel AS,Krishnaswaemy P,Richards M,et al. The New England Journal of Medicine . 2002
- [10] Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure with symptomatic left ventricular dysfunction. Maeda K,Tsuatamoto T,Wada A,et al. American Heart Journal . 1998